Accessibility Menu

Accessibility Statement

https://cannassure.life מחויב לספק באתר תוכן נגיש לקהל הרחב ככל שניתן, ללא כל קשר לטכנולוגיה בה נבנה האתר. אנחנו פועלים לעדכן ולהטמיע את כללי הנגישות ככל שניתן בהתאם לעקרונות תקן הנגישות. האתר עומד בהתאם לדרישות הנגישות לרמה 2 (AA) של ארגון W3C . בקישורים תמצאו פירוט התנאים בהם עומד האתרבעברית ובאנגלית. בנוסף האתר נבנה לפי התקן של W3C ל- CSS ו- HTML האתר מותאם לתצוגה בדפדפנים המובילים.

מבנה האתר והתאמות נגישות

תכני האתר כתובים באופן מסודר והיררכי. במידת הצורך קיימים הסברים לצד התוכן.

לכל התמונות באתר יש הסבר טקסטואלי חלופי (alt).

איזורי הפוקוס מסומנים באופן ברור.

חוקי ARIA

באתר זה הוטמעו חוקי ARIA העוזרים לפרש את תוכן האתר בצורה מדויקת וטובה יותר, עבור קןראי מסך, והוטמעו הודעות והתראות יחודיות לפריטים אנטראקטיבים שונים (פופ-אפים טפסים וכו’)

תפריט נגישות

באתר קיים תפריט נגישות ייעודי. ניתן לפתוח אותו בלחיצה על האייקון . דרך התפריט ניתן לעצור אנימציות, להגדיל קונטרסט, להדגיש קישורים ולשנות את גודל הפונט.

נתקלתם בבעיה? ספרו לנו!

באתר זה הושקעו מאמצים רבים על מנת להפוך אותו לנגיש ושימושי עבור כלל הגולשים. אנחנו משתדלים לשמור ולתחזק את האתר ברמה הטובה ביותר. במידה ומצאתם ו/או נתקלתם בקשיים בגלישה באתר, אל תהססו לדווח לנו לכתובת המייל: customers@cannassure.life.

אנחנו נטפל בבעיה ונחזור אליכם בהקדם עם פרטים על טיפולה.

תאריך עדכון אחרון של ההצהרה: 20/06/19

We do it right.

Our Story

In 2016, Cannassure co-founder and entrepreneur Nir Peles set out on a challenge, to raise the standards of medical cannabis in the global market. Three years later, he’s excited to see his vision coming true.

A close friend had been living with chronic pain for years. After treating with CBD, he experienced great relief but was unable to experience consistent alleviation of pain, due to the instability of products in the market. Nir and business partner Shimon Bar-Kama owned a successful botanical extraction and manufacturing company and saw an opportunity to apply their know-how and experience of precision extracting to medical cannabis.

Their vision was to become a leading, world-class, trusted developer and provider of top-quality-grade medical cannabis products. They wanted to ensure consistent, uniform and stable medical cannabis products that would be reliable and effective for different therapeutic treatments. They aspired to make medical cannabis products at a pharmaceutical level, in formulated and precise dosages. Nir’s vision came true – Canassure currently manages They embarked on building a state-of the-art medical cannabis operation that embodies all the stages of product creation, from seed to package, to ensure a quality second-to-none, alongside research and development of innovative products and technologies.



Leadership

  • Nir Peles, CPA, MBA, MA(LAW)

    Nir Peles, CPA, MBA, MA(LAW)

    Founder & Chairman of the Board

    A seasoned entrepreneur with extensive knowledge in business development and company transformation. A former executive at Bluephoenix Solutions (NASDAQ: MDSY) and Alcobra Pharma (NASDAQ: ADHD), Mr. Peles holds a BA in Economics and Accountancy from the Hebrew University of Jerusalem and an MBA and MA (Law) degree from Tel Aviv and Bar Ilan Universities.

  • Steven Eitan

    Steven Eitan

    VP Strategy

    Bringing 30 years of experience in leading and managing international biomed and hi-tech companies from start-up to market penetration and sales, including business and clinical strategy, raising finance, technological development, establishing marketing and sales systems. Over the years, Steven has managed publicly traded companies including Exalenz Bioscience (TASE: EXEN) and Micromedic Technologies (TASE: MCTC).

  • Hadar Cohen

    Hadar Cohen

    Production Manager

    With 20 years of manufacturing experience in the pharmaceutical industry, Mr. Cohen has served as the Production Manager at Kamada Ltd. (TASE: KMDA, NASDAQ: KMDA). Well versed in FDA regulatory processes, cGMP requirements and manufacturing processes in a cleanroom environment, Mr. Cohen brings extensive knowledge of drug developmental processes and sterile operations. He has a Bachelor's degree in Bio-Tech Enginerering and Industrial Management from Sapir College.

  • Alon Bilu

    Alon Bilu

    Senior Agronomist

    Bringing over 25 years experience in agriculture and agritech management, Mr. Alon Bilu is an experienced Agronomist with vast skills in plant breeding and cultivation. He is an expert in planning and outfitting agricultural systems for plant based food and seed production. During his extensive career, he led the Growth Department at Evogene (Nasdaq: EVGN) and the new seed production department at Syngenta, leading biotech companies. Mr. Bilu holds a degree in Agriculture, Food and Environmental Quality B.Sc.Agri and M.Sc.Agri from the Hebrew University of Jerusalem, Faculty of Rehovot.

  • Trevor Meredith

    Trevor Meredith

    Development Engineer

    Bringing over 40 years of experience in the fields of extraction, evaporation and drying techniques, Mr. Meredith has served throughout his career as QA Manager, R&D Manager, Chief Technologist and Senior Process Engineer, while supporting raw material purchasing programs, international production operations and auditing international suppliers. Mr. Meredith holds a Diploma in Sugar Chemistry manufacturing from the Queensland Institute of Technology and studied at The Sugar Research Institute of Australia.

  • Nissim Balas

    Nissim Balas

    Process Development & Quality Assurance Manager

    Bringing extensive experience in the Biopharmaceutical/Biotechnology/Biochemistry industry, in the field of Chemistry Manufacturing and Control (CMC) in Down Stream Process (DSP) development and in Quality Assurance management. Including: * Protein purification process for biological/biopharmaceutical products (involving formulation development and analytical methods for proteins). * Research and development in biology/Biochemistry. * Quality Assurance management. Including: Documentation control, Scientific review and approval of Development Reports, Approval of Validation Protocols and Reports, Participated in internal/external audits, etc.

  • Prof. Tamar Peretz

    Prof. Tamar Peretz

    Prof. Tamar Peretz, MD serves as Head of Sharett Institute of Oncology of Hadassah-Hebrew University Medical Center at Jerusalem, Israel. Professor Peretz specializes in cancer research and particularly in breast cancer.

  • Dr. Shimon Amsalem

    Dr. Shimon Amsalem

    Dr. Amsalem is a Pharmaceutical and Biotech consultant with expertise in formulation development, drug discovery and drug delivery. Currently Chief Scientist, Delivery Technologies, ADAMA Agricultural Solutions. CSO at SpacePharma (Herzliya, Israel), development of lab-on-chips nanosatellites as microgravity research tools. Previously CSO at Marval Pharma Ltd. (Netanya, Israel) development of encapsulated iodinated products for CT imaging. CEO and Founder of Nextar ChemPharma Solutions Ltd. a contract manufacturing and outsourcing company for pharmaceutical and analytical services for the Biotech/Pharma/medical devices industry. PhD in Pharmacology from the School of Pharmacy, Master in Pharmaceutical Sciences, School of Pharmacy, B. Sc. in Chemistry, all degrees from the Hebrew University of Jerusalem. Post-doctoral Fellow at the Walter Reed Army Institute of Research, Washington DC. Worked in several international pharmaceutical industries: Nova Pharmaceutical Corp., Baltimore, MD; Alergia Immunologia Abello SA, Madrid, Spain; Pharmos Corp., Iselin, NJ and Rehovot.

  • Dr. Yafit Stark

    Dr. Yafit Stark

    Dr. Stark established and managed the Global Clinical Research Departmnt and was a member of the leadership team of Teva’s Innovative R&D Division.Dr. Stark has over 30 years of experience in clinical development processes according to global and Israeli regulatory standards. In her senior positions at Teva, Dr. Stark lead the clinical development of the company’s products, including Teva’s flagship product, Copaxone, for the treatment of Multiple Sclerosis. Dr. Stark holds a PhD in Pathology from the Sackler School of Medicine, Tel Aviv University, and a Post-Doctorate in Immuno Histopathology.

Executive Team

  • Nir Peles, CPA, MBA, MA(LAW)

    Nir Peles, CPA, MBA, MA(LAW)

    Founder & Chairman of the Board

  • Steven Eitan

    Steven Eitan

    VP Strategy

Team

  • Hadar Cohen

    Hadar Cohen

    Production Manager

  • Alon Bilu

    Alon Bilu

    Senior Agronomist

  • Trevor Meredith

    Trevor Meredith

    Development Engineer

  • Nissim Balas

    Nissim Balas

    Process Development & Quality Assurance Manager

Scientific Advisory Board

  • Prof. Tamar Peretz

    Prof. Tamar Peretz

  • Dr. Shimon Amsalem

    Dr. Shimon Amsalem

  • Dr. Yafit Stark

    Dr. Yafit Stark

Our Partners

  • Solbar Food Technologies

    Solbar Food Technologies

    Cannassure was founded by Solbar Food Technlogies, a leading food manufacturer, with 60 years of applied industrial expertise and know-how. Solbar extracts and processes botanicals, in large industrial scale, operating in accordance with top-quality standards. The Solbar Group provides Cannassure with skillful mastery accumulated over decades of successful operation, having served customers over the years that included leading, global food and pharmaceutical companies. They have provided Cannassure with facilities, labs, skilled personnel and investment funds. They remain Cannassure's major stakeholder.

  • Hadassah Medical Ltd.

    Hadassah Medical Ltd.

    Cannassure has signed a mutual agreement with Hadassah Medical to market and sell medical cannabis oil worldwide under the Hadassah Medical brand name and to collaborate with Cannassure in their pharmaceutical R&D program of cannabinoid based medicine. Hadassah Medical, is a wholly owned subsidiary of the Hadassah Medical Organization, and leads Hadassah's business development ambitions. The company is part of Hadassah's medical centers in Israel and abroad, which include two university hospitals in Jerusalem as well as schools of medicine, dentistry, nursing, and pharmacology affiliated with the Hebrew University of Jerusalem.

  • Israel Innovation Authority

    Israel Innovation Authority

    The IIA has recognized Cannassure's activity as innovative and has granted us financial support for the application and modification of our botanical extraction methods to medical cannabis.

Interested in next generation medical cannabis opportunities? Become our partner

Partner With Us

Our Vision

Cannassure's vision is to become a leading, world-class, trusted developer and provider of top-quality medical grade cannabis products as well as pharmaceutical cannabinoid medicines, addressing a broad range of unmet medical needs.

Our Mission

Cannassure is developing and commercializing a wide range of effective, high standard and affordable medical cannabis products as well as pharmaceutical cannabinoid medicines, to enhance treatment and improve people's quality of life worldwide. We ensure the highest standards by facilitating a holistic integrated production system including an advanced indoor-aeroponic grow facility that is controlled and pristine, a state-of-the-art extraction and processing facility, together with scientifically advanced R&D. Cannassure is committed to quality, excellence, innovation, and integrity.

Responsibility

Commitment to Quality

Cannassure is committed to developing and producing medical cannabis products of the highest quality. We cultivate our cannabis according to IMC-GAP standards. We grow indoors in a controlled and clean environment to yield the highest quality, pure and consistent cannabis for use in our products. Our high-quality cannabis product range is processed in accordance with IMC-GMP standards, with quality assurance protocols, testing both our unprocessed cultivated cannabis and our manufactured products at different stages of production to ensure pure, effective, stable and consistent products for the duration of their entire shelf life.

Contact Us

    * Required Fields

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.